TF and cancer: Performing the analysis on a per-patient level and focusing on the three patients with the largest numbers of both normal and tumor epithelial cells revealed a similar skew towards inactivation with 8, 15, and 21 TFs exhibiting significantly lower activity across cancer cells (Fig. 4d), and with effectively no TF exhibiting increased activity.